Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Fibroma ultrasound
Introduction
Overview
Overview
Ultrasound may be helpful in the diagnosis of fibroma. Findings on ultrasound suggestive of fibroma include solid, hypoechoic masses with ultrasound beam attenuation.
Ultrasound
Ultrasound
On ultrasound, fibromas most commonly manifest as solid, hypoechoic masses with ultrasound beam attenuation.
Ovarian Fibroma
On ultrasound, ovarian fibroma most commonly manifest as solid, hypoechoic masses with ultrasound beam attenuation. As such, they may appear similar to a pedunculated subserosal uterine fibroid. However, the sonographic appearance can be variable and some tumors can rarely have cystic components.[1][2][3][4]
Uterine Fibroma
- Uncomplicated leiomyomas are usually hypoechoic, but can be isoechoic, or even hyperechoic compared to normal myometrium
- Calcification is seen as echogenic foci with shadowing
- Cystic areas of necrosis or degeneration may be seen
References
References
- ↑ Chen, Hui; Liu, Yan; Shen, Li-fei; Jiang, Mei-jiao; Yang, Zhi-fang; Fang, Guo-ping (2016). “Ovarian thecoma-fibroma groups: clinical and sonographic features with pathological comparison”. Journal of Ovarian Research. 9 (1). doi:10.1186/s13048-016-0291-2. ISSN 1757-2215.
- ↑ Liu, Yan; Zhang, Hui; Li, Xiaoqian; Qi, Guiqin (2016). “Combined Application of Ultrasound and CT Increased Diagnostic Value in Female Patients with Pelvic Masses”. Computational and Mathematical Methods in Medicine. 2016: 1–5. doi:10.1155/2016/6146901. ISSN 1748-670X.
- ↑ Sayasneh, Ahmad; Ekechi, Christine; Ferrara, Laura; Kaijser, Jeroen; Stalder, Catriona; Sur, Shyamaly; Timmerman, Dirk; Bourne, Tom (2015). “The characteristic ultrasound features of specific types of ovarian pathology (Review)”. International Journal of Oncology. 46 (2): 445–458. doi:10.3892/ijo.2014.2764. ISSN 1019-6439.
- ↑ Sconfienza, L.M.; Perrone, N.; Delnevo, A.; Lacelli, F.; Murolo, C.; Gandolfo, N.; Serafini, G. (2010). “Diagnostic value of contrast-enhanced ultrasonography in the characterization of ovarian tumors”. Journal of Ultrasound. 13 (1): 9–15. doi:10.1016/j.jus.2009.09.007. ISSN 1971-3495.
- ↑ Peng, Song; Zhang, Lian; Hu, Liang; Chen, Jinyun; Ju, Jin; Wang, Xi; Zhang, Rong; Wang, Zhibiao; Chen, Wenzhi (2015). “Factors Influencing the Dosimetry for High-Intensity Focused Ultrasound Ablation of Uterine Fibroids”. Medicine. 94 (13): e650. doi:10.1097/MD.0000000000000650. ISSN 0025-7974.
- ↑ Kim, Young-sun (2017). “Clinical application of high-intensity focused ultrasound ablation for uterine fibroids”. Biomedical Engineering Letters. 7 (2): 99–105. doi:10.1007/s13534-017-0012-9. ISSN 2093-9868.
- ↑ Marsh, Erica E.; Ekpo, Geraldine E.; Cardozo, Eden R.; Brocks, Maureen; Dune, Tanaka; Cohen, Leeber S. (2013). “Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18–30 years old): a pilot study”. Fertility and Sterility. 99 (7): 1951–1957. doi:10.1016/j.fertnstert.2013.02.017. ISSN 0015-0282.
- ↑ Sarkodie, Benjamin Dabo; Botwe, Benard Ohene; Ofori, Eric K. (2016). “Uterine fibroid characteristics and sonographic pattern among Ghanaian females undergoing pelvic ultrasound scan: a study at 3-major centres”. BMC Women’s Health. 16 (1). doi:10.1186/s12905-016-0288-4. ISSN 1472-6874.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2], Simrat Sarai, M.D. [3]